Axis Pharmaceuticals is a Pakistan-based startup in the manufacturing and pharmaceutical industries. Established in 2009, the company operates a purpose-built facility in Faisalabad, spread over 2 acres, which is cGMP compliant and oriented towards growth and innovation in quality products. The company holds ISO certifications including ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018, and its QC laboratory is ISO 17025:2017 accredited. The impressive facility and certifications indicate strong emphasis on quality and compliance, crucial in the pharmaceutical industry. With no recent investment data available, it is unclear if Axis Pharmaceuticals is seeking external funding or has recently secured it. Nevertheless, the company's diligence in adhering to international quality standards could position it as an attractive investment opportunity for venture capital firms seeking exposure to the pharmaceutical manufacturing sector.
There is no investment information
No recent news or press coverage available for Axis Pharmaceuticals.